The effect of itraconazole in the treatment of allergic fungal sinusitis

Phase 2

Completed

• Conditions: chronic sinusitis; fungal sinusitis.

• Registration Number: IRCT201204049375N1
• Lead Sponsor: Ahvaz Jundishapour University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

patients with diagnosis of allergic fungal sinusitis based on culture and pathology.
Exclusion criteria: history of previous sinus surgery, history of systemic disease, pregnant or nursing mother, patient who display rising of hepatic enzymes during treatment with itraconazole.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Therapeutic effect of Itraconazol on fungal sinusitis. Timepoint: three months after intervention. Method of measurement: Endoscopic and CT scan findings.

Secondary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: three months after intervention. Method of measurement: Snot-20 questionnaire.